To further examine the potential mechanisms for BCR activation in GCB DLBCL, we recently investigated the expression of several negative regulators of this pathway in a series of BCR-dependent and BCR-independent DLBCL cell lines [26]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.